Catalyst Wire Dossier Catalyst Wire Dossier

SRD174 Cream

· Serentis Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SRD174 Cream, covering 2009-10-30 to 2009-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIa Safety and Efficacy Study of SRD174 Cream in Patients With AD-associated Pruritus [Phase 2]

See pricing